Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience

PURPOSE: To assess the outcome and response of transcutaneous retrobulbar injection of amphotericin B (TRAMB) in post-coronavirus disease of 2019 (COVID-19) rhino-orbito-cerebral mucormycosis (ROCM) and to establish a scoring system in guiding treatment modalities. METHODS: An interventional, prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramamurthy, Lakshmi B, Bhandari, Ridhi, Kanakpur, Savitha, Thejaswini, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Expedited Publications, Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114606/
https://www.ncbi.nlm.nih.gov/pubmed/35225564
http://dx.doi.org/10.4103/ijo.IJO_2356_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114606/
https://www.ncbi.nlm.nih.gov/pubmed/35225564
http://dx.doi.org/10.4103/ijo.IJO_2356_21

Ejemplares similares